At this critical time for the biomanufacturing industry, it is vital to discuss the ways in which production can be optimised and challenges addressed:
· Reviewing the current SUS landscape
· Outlining the ways in which SUS have supported and enabled biomanufacturing during the COVID-19 pandemic
· Confronting the challenges facing the industry and setting out priorities to be addressed
· Evaluating the performance of single use bioreactors and filtration units through real-world case studies
· Analysing the underperformance of smaller single use elements over a number of years in different facilities to illustrate the challenges still to be addressed
A highlight of previous Pharma IQ events and now back at Disposable Solutions for Biomanufacturing 2022! It’s been two years since we were able to meet in person, so this is your opportunity to get out from behind the computer screen, meet your peers and share best practices. You will have 2 minute conversations to enable you to introduce yourself to your peers, add to your contact pool and begin the discussions that will continue over the next two days. Participants are invited to share
· Latest trends in single-use technologies used in biomanufacturing
· Development of biotherapeutics (nature and man-made molecular entities/submicron particles and mammalian cells) using single-layer fluoropolymer bags
· The importance of material selection at the interface between drug and primary container
Discussing the challenges will only get you so far – you need to take solutions back to your sites! Use this opportunity to see solutions in action and pose your most pressing questions to leading technology specialists.
Featuring companies including: Levitronix
This quick-fire format will enable delegates to take a deep-dive into a variety of topics that address the challenges, whilst engaging in
collaborative, problem-solving focused discussions with their peers. At the end of the roundtable session, each of the moderators will provide a brief summary of the different discussions that have taken place at their tables.
Each discussion session will last for twenty minutes, with a five-minute break to rotate to the next discussion group of your choosing. Delegates will get the opportunity to take part in two twenty-minute discussion groups. At the end of the whole session, the moderators from each of the roundtables
will each deliver a five-minute feedback summary of all the discussions that took place at their table.
Bringing together biopharma manufacturers and industry suppliers, this important panel debate will consider questions including:
· Balancing the demands of COVID-19 related therapeutics manufacturing with the development and manufacturing of other critical biopharmaceuticals
· What steps can biopharmaceutical manufacturers take to protect their supply chains?
· What steps are suppliers taking to support biopharmaceutical producers?
· Should the industry consider moving towards greater standardisation of SUS to tackle the issue?
· What is the impact of supply chain disruption on safety validation and compliance?
In-person events offer the opportunity to relax and socialise with your peers and colleagues, which helps to build deeper connections and consolidate your take-aways from the conference sessions. Once the formal conference day has concluded, this is your chance to engage with your fellow conference attendees and continue the conversations started during the day. Enjoy!